1 / 92

Skin cancers

Skin cancers. Outline. Basal cell carcinoma Squamous cell carcinoma Cutaneous T-cell Lymphoma Paget’s & Extramammary Paget’s Cutaneous metastases Melanoma. Basal Cell Carcinoma. Basal Cell Carcinoma. Most common skin malignancy Metastasis extremely rare – 0.0028-0.55%

kessie-shaffer
Download Presentation

Skin cancers

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Skin cancers

  2. Outline • Basal cell carcinoma • Squamous cell carcinoma • Cutaneous T-cell Lymphoma • Paget’s & Extramammary Paget’s • Cutaneous metastases • Melanoma

  3. Basal Cell Carcinoma

  4. Basal Cell Carcinoma • Most common skin malignancy • Metastasis extremely rare – 0.0028-0.55% • locally invasive & destructive • Demographics • older persons • increasing in those <40 • Often on sun-exposed areas • 85% on head/neck, esp nose • Can occur on sun-protected areas

  5. Basal Cell CA • Clinical subtypes: • Nodular – most common • Pigmented • Sclerosing or Morpheaform • Superficial

  6. Nodular BCC • Most common • Pearly, white or pink, telangiectases, rolled borders, center can ulcerate

  7. Pigmented BCC • Brown, blue, or black • Dark-complexioned persons – Hispanics, Asians • Borders still pearly with telangiectases • DDx: Melanoma

  8. Sclerosing/Morpheaform BCC • Pale yellow/white, waxy, firm, depressed and scar-like, indistinct borders • History of prior cryotherapy • Need Mohs or wide excision

  9. Superficial BCC • Least aggressive, but can be difficult to diagnose • Mimic eczema or psoriasis • Alcohol swab reveal pearly border + telangiectases

  10. Treatment Modalities • Imiquimod (Aldara): • FDA-approved for superficial BCC • little or no scarring, spares tissue • variable or unpredictable response • Electrodessication & Curettage (ED&C): • Best for nodular and small superficial forms • Leaves a noticeable scar • Best for low risk sites – trunk, extremities

  11. Treatment Modalities • Excision: • Offers standard margin check • Large long scar • Mohs micrographic surgery • Tissue sparing procedure • Gold standard with 100% margin check • Expensive, labor intensive • Reserved for: • High risk sites • Head & neck, shins, hands, tight areas • High risk subtypes • Recurrent disease • Aggressive histology • Sclerosing, infiltrating, micronodular, basosquamous

  12. Squamous Cell Carcinoma

  13. What is the precursor lesion for squamous cell carcinoma? • Actinic keratosis

  14. Actinic Keratosis • Partial thickness epidermal atypia • Sun exposure, immunosuppressed • Erythematous scaly papules, not indurated • Smaller lesions often easier felt than seen • Can be hypertrophic or even tall (cutaneous horn)

  15. AK Management • Sun protection • Cryotherapy – best for isolated lesions • Multiple or extensive lesions: • 5-fluorouracil (5-FU/Efudex) • Imiquimod (Aldara) • Solaraze/Diclofenac – milder reaction than Efudex • Chemical peels – pain; wound care • Photodynamic therapy (PDT) – pain, minimal wound care, expensive

  16. Why we treat AKs… • 1-5% risk of SCC transformation per year • More likely in hypertrophic AK • Suspicious for transformation: • Induration • Oozing, easy bleeding • Recurrent after cryosurgery

  17. Squamous Cell Carcinoma • 2nd most common skin cancer • High association • UV exposure • located mostly on sun-exposed sites • scalp, forehead, dorsal nose, superior ears, dorsal hands • Prior radiation • Marjolin’s ulcer • SCC arising on sites of burns, chronic wound/inflammation • Immunosuppression (SCC >> BCC) • Transplant patients

  18. Squamous Cell Carcinoma • Scaly papules or plaques with induration, erosion, bleeding • May be tender • Recurrent after cryosurgery

  19. Squamous Cell Carcinoma • Local spread can be extensive • Follows path of least resistance • Subcutaneous & fascial planes, perineural, perichondrium/periosteum, perivascular • Treatment similar to BCC except: • 4-6 mm margins for standard excision • Electrodessication & curettage • for small, thin SCC’s in low risk areas

  20. SCC • Metastasis rate: up to 5.2% • Lymphatics & hematogenous • Higher risk lesions: • Size > 2 cm • Depth > 4 mm • Aggressive histology • Lip or ear location • Immunosuppressed • Prior XRT • Burns or chronic inflammation

  21. Bowen’s Disease • Squamous cell carcinoma in-situ • full thickness atypia • Well-demarcated, erythematous, scaly, thin papules/plaques • Most common on legs of women & scalp/ears of men • Mimic psoriasis or eczema

  22. Bowen’s Disease • Grows slowly, can become invasive SCC • Treatment • Small lesions – ED&C, 5-FU, Aldara • Large lesions – Excision, 5-FU, Aldara

  23. Erythroplasia of Queyrat • SCC in-situ of penis or vulva • Moist glistening, red, thin plaque (under foreskin) • Grows slowly, can become invasive • Treatment • Aldara or 5-fluorouracil (5-FU) • Mohs if around or into urethra

  24. Keratoacanthoma • Smooth dome-shaped nodule with keratin-filled crater • Rapid growth/expansion  regresses with scarring

  25. Keratoacanthoma • Considered as a well-differentiated form of SCC • Treatment • ED&C, blunt dissection, or excision • Intralesional injections • 5-FU, Bleomycin, MTX

  26. Verrucous Carcinoma • Exophytic, slow-growing, low-grade SCC • Rarely metastasize • Often mistaken for warts • Treatment: • Excision • Avoid XRT, risk of aggressive transformation

  27. Verrucous Carcinoma • 3 subtypes: • Buschke-Lowenstein • Genital form • HPV 6, 11 • Oral florid papillomatosis • tobacco chewing • poor oral hygiene • Epithelioma cuniculatum • Plantar feet • Older men

  28. Arsenical Keratoses • Discrete round keratoses • Appear 20 yrs after chronic arsenic exposure • Most common on palms and soles • Not fatal, but may persist indefinitely • Pain, bleeding, fissuring, and ulceration • Rare in US • More common in 3rd world • Risk of SCC degeneration

  29. Cutaneous T-cell Lymphoma

  30. Cutaneous T-Cell Lymphoma • Malignant T-cells with cutaneous lymphoid antigen (CLA) localize to skin • Most common form of CTCL is mycosis fungoides • 4 stages • Pre-MF • Patch • Plaque • Tumor • Prognosis good for first 2 stages then worsens

  31. Cutaneous T-Cell Lymphoma • Erythroderma can occur in any stage • Lesions like persistent eczema/tinea, often sun-protected areas • Difficult to diagnose in early stages • Average of 6 biopsies before diagnosis made • Clinical & histology difficult to distinguish from other inflammatory disorders • Monoclonality on T-cell gene rearrangement study is helpful

  32. Mycosis Fungoides • Pre-MF: diagnosis suspected but not proven • Nonspecific pruritis and/or eruption • Persists or recurs over months to years • Can mimic eczema

  33. Mycosis Fungoides • “Patch” stage: diagnosis possible with histo • Similar morphology pre-MF • Poikiloderma vasculare atrophicans: variant of MF

  34. Mycosis Fungoides • Plaque stage: • thickening of epidermis • Dusky red-brown plaques with variety of shapes • Pruritis can be intense • Can remain stable, regress, or progress

  35. Mycosis Fungoides • Tumor stage • may progress from patch or plaque stage lesions or arise de novo • Necrosis/ulceration possible

  36. Mycosis Fungoides • Sezary syndrome • leukemic form MF • Triad: • Erythroderma • Lymphadenopathy • Sezary cells • lymphocytes with cerebriform nuclei

  37. MF Treatment • Patch stage: • Group I topical steroids, topical nitrogen mustard, Bexarotene (RXR retinoid) • Generalized lesions • PUVA/UVB • Electron beam radiation • patch/plaque/tumor • most reliable for generalized; high relapse, side-effects • Extracorporeal photophoresis • Sezary syndrome & erythrodermic MF • PUVA of extracted lymphocytes then reinfused into patient

  38. Paget’s Disease

  39. Paget’s Disease of the Breast • Invasion of skin from underlying breast cancer • Unilateral nipple erythema with serous drainage • Appears eczematous, but fixed & indurated with sharp margins

  40. Paget’s Disease of the Breast • Often confused with eczema of the breast • Good diagnostic test: • Trial of potent steroid (Lidex or Clobetasol) x 2 weeks • If improved or resolved  most likely eczema • If not  need to biopsy to exclude malignancy • Treatment: • Excision

  41. Extramammary Paget’s Disease • Usually genital or perianal area • Associated with underlying malignancy • Location related to internal CA • Perianal – GI malignancy • Genital – GU malignancy

  42. Extramammary Paget’s Disease • White-to-red scaling or macerated plaque • Often persistent itching or burning • Treatment • Excision, XRT

  43. Cutaneous Metastases

  44. Cutaneous Metastases • Usually present as asymptomatic, firm, deep nodules • Metastases to skin in 2-10% • Most common primaries: • Women: • Breast (69%) • Colon (9%) • Melanoma (5%) • Ovarian (4%) • Men: • Lung (24%) • Colon (19%) • Melanoma (13%) • SCC oral cavity (12%)

  45. Cutaneous Metastases • Primary tumors that metastasize to scalp • Thyroid carcinoma (especially papillary carcinoma) • Renal cell carcinoma • Nodules with alopecia

  46. Cutaneous Metastases • Metastasis to the umbilicus • Sister Mary Joseph’s nodule • solitary, firm, fissured nodules • represents advanced disease and carries a very poor prognosis • Adenocarcinoma of the stomach • Adenocarcinoma of the large bowel • Ovary • Pancreas • Endometrium • Breast

  47. Cutaneous Metastases • Breast metastasis to skin has variable appearance • Resemble cellulitis • Carcinoma en cuirasse • hard infiltrated plaque with leathery appearance

  48. Melanoma

More Related